A California jury found that Bayer’s Roundup weedkiller was not the cause of a woman’s non-Hodgkin’s lymphoma, Bayer said on December 9, delivering the chemical giant a second trial victory over claims the popular herbicide causes cancer.

AbbVie Inc. settled claims by New York and two of the state’s counties that the company fueled an epidemic of opioid addiction in the state, on the day jurors were expected to hear closing arguments at the end of a five-month trial.

Martin Shkreli

The U.S. Federal Trade Commission and seven states on December 7 settled claims accusing Vyera Pharmaceuticals of trying to block generic versions of the company’s life-saving drug Daraprim, but are preparing for a Dec. 14 trial against accused mastermind Martin Shkreli.

AstraZeneca agreed to pay a $560,000 settlement to resolve allegations of gender and racial discrimination filed by employees at the company’s Wilmington, Del. headquarters. 

AstraZeneca and the European Commission reached a settlement on the delivery of 200 million pending Covid-19 vaccine doses by the drugmaker, ending a row about shortages that had weighed on the company and the region’s vaccination campaign.

U.S. state attorneys general said Johnson & Johnson and a company unit agreed to pay nearly $117 million to settle litigation over deceptive marketing of transvaginal surgical mesh devices.

A New Jersey jury cleared Johnson & Johnson of liability in a lawsuit brought by a man who said asbestos in the company’s talcum powder products caused his mesothelioma.

INSYS Therapeutics Inc. announced today that the company reached an agreement in principle with the Department of Justice to settle the DOJ’s civil and criminal investigation into inappropriate sales and commercial practices by some former company employees.